Pilar Rosel

819 total citations
41 papers, 637 citations indexed

About

Pilar Rosel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pilar Rosel has authored 41 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pilar Rosel's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Diabetes and associated disorders (6 papers) and Diabetes Management and Research (5 papers). Pilar Rosel is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Diabetes and associated disorders (6 papers) and Diabetes Management and Research (5 papers). Pilar Rosel collaborates with scholars based in Spain, Sweden and Canada. Pilar Rosel's co-authors include Belén Arranz, Miguel Navarro, Luis San, Mikel Urretavizcaya, Rosa Dueñas, Nicolás David Ramírez, J.M. Hernández Sánchez, Paloma Fernández, José M. Menchón and Julio Vallejo and has published in prestigious journals such as Biological Psychiatry, Clinical Chemistry and Psychological Medicine.

In The Last Decade

Pilar Rosel

39 papers receiving 606 citations

Peers

Pilar Rosel
Wendy Shelly United States
Jiamei Lian Australia
Sally Martin Australia
H.R. Bourne United States
Gareth W. Roberts United Kingdom
Lucy A. Templeman United Kingdom
Wendy Shelly United States
Pilar Rosel
Citations per year, relative to Pilar Rosel Pilar Rosel (= 1×) peers Wendy Shelly

Countries citing papers authored by Pilar Rosel

Since Specialization
Citations

This map shows the geographic impact of Pilar Rosel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Rosel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Rosel more than expected).

Fields of papers citing papers by Pilar Rosel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Rosel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Rosel. The network helps show where Pilar Rosel may publish in the future.

Co-authorship network of co-authors of Pilar Rosel

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Rosel. A scholar is included among the top collaborators of Pilar Rosel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Rosel. Pilar Rosel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arranz, Belén, Pilar Rosel, Luis San, et al.. (2007). Low baseline serotonin-2A receptors predict clinical response to olanzapine in first-episode schizophrenia patients. Psychiatry Research. 153(2). 103–109. 10 indexed citations
2.
Arroyo, Amanda, Pilar Rosel, & Thomas U. Marron. (2005). Cerebrospinal fluid: postmortem biochemical study. Journal of Clinical Forensic Medicine. 12(3). 153–156. 30 indexed citations
3.
Arranz, Belén, Pilar Rosel, Nicolás David Ramírez, et al.. (2004). Insulin Resistance and Increased Leptin Concentrations in Noncompliant Schizophrenia Patients but Not in Antipsychotic-Naive First-Episode Schizophrenia Patients. The Journal of Clinical Psychiatry. 65(10). 1335–1342. 136 indexed citations
5.
Arranz, Belén, Pilar Rosel, Salvador Sarró, et al.. (2003). Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Research. 118(2). 165–174. 23 indexed citations
6.
Vallejo, J., Pilar Rosel, Belén Arranz, et al.. (2002). Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patients. Journal of Affective Disorders. 72(1). 95–101. 3 indexed citations
7.
Rosel, Pilar, Belén Arranz, Mikel Urretavizcaya, et al.. (2002). Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres. Psychiatry Research. 111(2-3). 105–115. 9 indexed citations
8.
Villabona, C, et al.. (2001). Water metabolism disturbances at different stages of primary thyroid failure. Journal of Endocrinology. 168(3). 435–445. 12 indexed citations
9.
Rosel, Pilar, Belén Arranz, Luis San, et al.. (2000). Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Research Neuroimaging. 99(3). 173–181. 62 indexed citations
11.
Rosel, Pilar, et al.. (1999). Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. Journal of Affective Disorders. 52(1-3). 225–233. 30 indexed citations
12.
Fernández-Montolí, Maria-Eulalia, et al.. (1999). Secretion and dual regulation between epidermal growth factor and transforming growth factor-β1 in MDA-MB-231 cell line in 42-hour-long cultures. Cancer Letters. 147(1-2). 25–29. 18 indexed citations
13.
Rosel, Pilar, Belén Arranz, Julio Vallejo, et al.. (1999). Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain. Neuroscience Research Communications. 24(2). 107–115. 4 indexed citations
14.
Huguet, Jordi, et al.. (1998). Immunological Quantitation of Nuclear Steroid Receptors to Optimize the Biological Classification of Breast Tumors. Tumor Biology. 19(4). 222–228. 2 indexed citations
15.
Rosel, Pilar, Belén Arranz, Julio Vallejo, et al.. (1998). Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains. Psychiatry Research Neuroimaging. 82(3). 161–170. 30 indexed citations
16.
Arranz, Belén, Pilar Rosel, Luis San, et al.. (1998). Characterization of the 5-HT 4 binding site in human brain. Journal of Neural Transmission. 105(6-7). 575–586. 14 indexed citations
17.
Rosel, Pilar, José M. Menchón, J. Vallejo, et al.. (1997). Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain. Journal of Neural Transmission. 104(1). 89–96. 25 indexed citations
18.
Rosel, Pilar, et al.. (1997). High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains. Journal of Neural Transmission. 104(8-9). 921–929. 15 indexed citations
19.
Contreras, Fernando, Miguel Navarro, José M. Menchón, et al.. (1996). Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controls. Psychological Medicine. 26(2). 301–307. 5 indexed citations
20.
Navarro, Miguel, et al.. (1989). ER-D5 antigen in breast cancer. Journal of Cancer Research and Clinical Oncology. 115(3). 290–291. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026